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Vesicle transport requires four steps: vesicle forma-
tion, movement, tethering, and fusion. In yeast, two
Rab GTPases, Ypt31/32, are required for post-Golgi
vesicle formation. A third Rab GTPase, Sec4, and
the exocyst act in tethering and fusion of these vesi-
cles. Vesicle production is coupled to transport via
direct interaction between Ypt31/32 and the yeast
myosin V, Myo2. Here we show that Myo2 interacts
directly with Sec4 and the exocyst subunit Sec15.
Disruption of these interactions results in compro-
mised growth and the accumulation of secretory
vesicles. We identified the Sec15-binding region on
Myo2 and also identified residues on Sec15 required
for interaction with Myo2. That Myo2 interacts with
Sec15 uncovers additional roles for the exocyst as
an adaptor for molecular motors and implies similar
roles for structurally related tethering complexes.
Moreover, these studies predict that for many path-
ways, molecular motors attach to vesicles prior to
their formation and remain attached until fusion.
INTRODUCTION
Vesicle transport is a fundamental process. Vesicles form, move,
are tethered at their destination, and ultimately fuse with the
acceptor membrane. In secretory vesicle transport, vesicles
are produced as post-Golgi vesicles and are moved along the
cytoskeleton by motor proteins. The vesicles are then tethered
to the plasma membrane by tethering factors, and ultimately
the vesicles fuse with the plasma membrane.
The unconventional myosin motor, myosin V, moves several
cargoes including secretory vesicles (Johnston et al., 1991),
melanosomes (Wu et al., 1997), the vacuole (Hill et al., 1996),
peroxisomes (Hoepfner et al., 2001), synaptic vesicles (Evans
et al., 1998; Prekeris and Terrian, 1997), and the endoplasmic
reticulum (Estrada et al., 2003; Tabb et al., 1998; Takagishi1156 Developmental Cell 21, 1156–1170, December 13, 2011 ª2011et al., 1996; Wagner et al., 2011). The globular tail domain
(GTD)/cargo-binding domain (CBD) of myosin V, located at its
C terminus, plays a critical role in the attachment of myosin V
to cargoes. The CBD interacts directly with cargo-specific
adaptor proteins that regulate the interaction of myosin V
cargoes. Recently, we solved the structure of the CBD of the
yeast myosin V motor, Myo2, and mapped the binding sites for
the adaptor/receptor proteins, Vac17, Inp2, and Ypt31/32, which
connect myosin V to the vacuole, peroxisome, and secretory
vesicles, respectively (Fagarasanu et al., 2009; Lipatova et al.,
2008; Pashkova et al., 2006).
In the yeast S. cerevisiae, each step in secretory vesicle trans-
port is essential for yeast viability. The Rab GTPases Ypt31/32
(Rab11 homologs) are required for secretory vesicle formation
from the trans-Golgi (Jedd et al., 1997). Myo2 is recruited to
these vesicles by Ypt31/32 (Lipatova et al., 2008). Ypt31/32,
along with phosphatidylinositol 4-phosphate, recruit Sec2,
a guanine nucleotide exchange factor (GEF), for the Rab GTPase
Sec4 (Mizuno-Yamasaki et al., 2010; Ortiz et al., 2002). Sec2
mediates a Rab GTPase cascade and recruits Sec4 (Rab8/10
homolog) (Ortiz et al., 2002; Walch-Solimena et al., 1997). The
nucleotide bound to Sec4 is converted from guanosine diphos-
phate (GDP) to guanosine triphosphate (GTP) by the GEF func-
tion of Sec2. Sec4 also binds to Myo2 (Santiago-Tirado et al.,
2011). In addition, Sec2 binds Sec15, a subunit of the vesicle-
tethering complex, the exocyst (Medkova et al., 2006), and
concomitantly Ypt31/32 are released (Mizuno-Yamasaki et al.,
2010). Sec15 then binds GTP-bound Sec4 (Guo et al., 1999).
Sec4 also functions with the t-SNARE, Sec9, to promote fusion
(Brennwald et al., 1994; Grosshans et al., 2006).
Myo2 moves secretory vesicles from the mother cell to the
growing tip of the daughter cell (Govindan et al., 1995). The
average velocity of movement of the Sec4-positive secretory
vesicle is 3 mm/s (Schott et al., 2002). In myo2 mutants, where
some or all of the Myo2 IQ motifs are deleted, these Sec4-posi-
tive vesicles move at a slower velocity. These observations
strongly suggest that movement of Sec4-positive vesicles is
mediated by Myo2 (Schott et al., 2002). Ypt31/32 (Lipatova
et al., 2008) and Sec4 (Santiago-Tirado et al., 2011) are each
candidate molecules that link secretory vesicles to Myo2. In
further support of this hypothesis, homologs of Ypt31/32 andElsevier Inc.
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Myosin V Interacts with the ExocystSec4 in other species interact with myosin V motors. Ypt31/32
are members of the Rab11 family. In Drosophila, Rab11 binds
myosin V (Li et al., 2007; Wu et al., 2005). There are three myosin
V motors in mammals: Va, Vb, and Vc. Mammalian Rab11 binds
myosin Vb (Roland et al., 2009). In addition, Sec4 is closely
related to the Rab8 and Rab10 families. Rab8 binds myosin Vb
and Vc (Ishikura and Klip, 2008; Rodriguez and Cheney, 2002;
Roland et al., 2009). Rab10 binds myosin Va, Vb, and Vc (Roland
et al., 2009).
It is likely that Rab GTPases are not the sole proteins required
to tether secretory vesicles to Myo2. Unlike Myo2, neither
Ypt31/32 nor Sec4 is present on secretory vesicles from their
formation through their fusion. Ypt31/32 are replaced by Sec4
at an as yet undefined point in the transport process. This raises
the question of how Myo2 remains attached to these moving
vesicles, and leads to the postulate that additional proteins are
involved in this attachment.
The CBD of myosin V is primarily composed of a-helical
bundles arranged as extended rods (Pashkova et al., 2006).
Remarkably, although there is no sequence similarity, all known
structures of the exocyst subunits are similar to each other (Dong
et al., 2005; Hamburger et al., 2006; Moore et al., 2007; Munson
and Novick, 2006; Sivaram et al., 2006; Wu et al., 2005) and
share the same unique fold with the Myo2 CBD (Croteau et al.,
2009; Moore et al., 2007; Pashkova et al., 2006). These observa-
tions raise the intriguing possibility that the CBD of myosin V
shares a similar molecular function with the exocyst complex,
and interacts with secretory vesicles via direct interaction with
the exocyst.
Here we show that Ypt31/32 and Sec4 bind to the same site on
Myo2. We further show that the exocyst-tethering complex is
also required to attach Myo2 to secretory vesicles. Myo2 inter-
acts directly with Sec15, at a site distinct from the Rab GTPase
site. Moreover, we map the site on Sec15 that binds to Myo2,
and identify a mutation on Sec15, that suppresses Myo2
mutants that are defective in binding Sec15. Together, these
studies show that Myo2 attaches to secretory vesicles through
direct binding to multiple proteins required for vesicle fusion,
as well as to proteins required for vesicle formation.
RESULTS
Sec4 Interacts with the Secretory Vesicle-Binding
Region of Myo2
Secretory vesicle transport is the only function of Myo2 that is
required for yeast viability. An intact motor and cargo-binding
(globular tail) domain of Myo2 are each required (Catlett et al.,
2000; Reck-Peterson et al., 1999; Schott et al., 1999). We iden-
tified surface residues on the Myo2 CBD that comprise the
secretory vesicle-binding site, L1331, L1411, Y1415, K1444,
and Q1447 (Figure 1A) (Pashkova et al., 2006), and subsequently
showed that these bind directly to the Rab GTPases Ypt31/32
(Lipatova et al., 2008). Support of the importance of this interac-
tion came from the observation that a lethal point mutation in the
center of the secretory vesicle-binding site of Myo2 could be
rescued by direct fusion of Ypt32 to the C terminus of Myo2-
Y1415R (Lipatova et al., 2008). This finding raised the question
of whether the Rab GTPase Sec4, which functions in a Rab
cascade after Ypt31/32 and is required for secretory vesicleDevelopmentatethering and fusion, also interacts with Myo2. Indeed, five inde-
pendent approaches indicate that Sec4 interacts with Myo2.
In a yeast two-hybrid test, Sec4 interacts with Myo2, and
notably, the Myo2-Y1415R mutation abolishes this interaction
(Figure 1B) (Santiago-Tirado et al., 2011). To test whether Sec4
binds to the same region on Myo2 as Ypt32, we tested each of
the secretory vesicle-binding site mutants: L1331S, L1411S,
Y1415R, and Q1447R. Each failed to interact with Sec4 (Fig-
ure 1B). In contrast, a vacuole-binding mutant, Myo2-N1304S,
which does not interact with Vac17 (Ishikawa et al., 2003), inter-
acts with Sec4 (Figure 1B). The two-hybrid studies strongly
suggest that Sec4 andYpt31/32bind to the same site (Figure 1A).
We could not determine whether the Myo2-K1444A mutant is
defective in binding to Sec4 because the Gal4 DNA-binding
domain fused to the Myo2-K1444A mutant showed self-activa-
tion (data not shown).
Recombinant Sec4 and Recombinant Myo2 Interact
In Vitro
To further test whether Myo2 interacts with Sec4, we used
recombinant proteins and performed pull-down experiments
from solubilized yeast lysates. Recombinant GST-Sec4 pulled
down endogenous Myo2 from yeast lysates (Figure 1C). Note
that GST-Sec4 also pulled down endogenous Sec15, a known
binding partner of Sec4 (Figure 1C) (Guo et al., 1999). This result,
as well as a previous study (Wagner et al., 2002), suggests that
Sec4 is in the same complex with Myo2.
Recombinant Myo2 CBD interacts with recombinant Sec4
(Santiago-Tirado et al., 2011). To test whether the interaction
between Myo2 and Sec4 is dependent on the nucleotide state
of Sec4, we used recombinant-purified Sec4-Q79L (GTP-locked
mutant) (Walworth et al., 1992), Sec4-S34N (a predicted
GDP-locked mutant) (Collins et al., 1997), and Sec4-N133I
(nucleotide-free mutant) (Walworth et al., 1989). We found that
His-tagged Myo2 CBD bound to GST-Sec4-Q79L but not to
GST-Sec4-S34N or GST-Sec4-N133I (Figure 1D).
To further test the interaction between Myo2 and Sec4, we
measured their affinity using surface plasmon resonance (SPR)
and observed a dissociation constant (KD) of 4.6 mM for Myo2
with Sec4(GppNHp) and a KD of 34.8 mM for Myo2 with
Sec4 without addition of nucleotide (see Table S1 and Figure S1
available online). The differences in affinity of Myo2 for Sec4
and Sec4(GppNHp) strongly suggest that this interaction re-
quires GTP.
Myo2 Interacts with Sec4 In Vivo
To test whether Myo2 and Sec4 interact in vivo, we used a split
GFP assay (Kerppola, 2008). Myo2 was fused to the N-terminal
half of the YFP variant Venus (vYFPN), whereas Sec4 was fused
to the C-terminal half of the YFP variant Venus (vYFPC). The YFP
signal is only detected when the N-terminal and C-terminal por-
tions of vYFP are brought into close proximity. Coexpression of
vYFPN fused to C-terminal end of Myo2,Myo2-vYFPN, and vYFPC
fused to N terminus of Sec4, vYFPC-Sec4, inmyo2D cells resulted
in a YFP signal in the growing bud or in themother-bud neck, sites
where secretory vesicles are delivered (Figure 1E). These results
indicate that Myo2 and Sec4 are in close proximity in vivo. Myo2-
vYFPN and vYFPC-Sec4 fusion proteins support viability of the
lethalmyo2D and sec4Dmutants, respectively (data not shown).l Cell 21, 1156–1170, December 13, 2011 ª2011 Elsevier Inc. 1157
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Figure 1. Myo2 Directly Interacts with Sec4
(A) Surface residues of the Myo2 CBD that bind vacuoles (blue) or secretory vesicles (red) (Ishikawa et al., 2003; Lipatova et al., 2008; Pashkova et al., 2006).
(B) Sec4 interacts with the secretory vesicle-binding region of Myo2. Yeast two-hybrid test of wild-type or mutant Myo2 CBD fused with the Gal4 DNA-binding
domain (BD), versus Sec4 or Vac17 fusedwith the Gal4 activation domain (AD). Plasmids cotransformed into yeast, grown on SC-LEU-TRP and replica-plated on
SC-LEU-TRP (control) or SC-ADE-HIS-LEU-TRP plus 3AT (test) plates; incubated at 24C for 9 days. Growth indicates protein-protein interactions.
(C) Sec4 and Myo2 are in the same complex. Purified bacterially expressed GST-Sec4 protein pulled down Myo2 and Sec15 from solubilized yeast lysates.
Proteins pulled down by GST (lane 1), GST-Sec4 (lane 2), and 8% of input yeast lysate (lane 3) analyzed by immunoblot with anti-Myo2 CBD antibodies (top),
Sec15 (middle), or by Coomassie brilliant blue (CBB) (bottom).
(D) Direct binding of Sec4 to the Myo2 CBD requires GTP. Purified GST-Sec4 pulled down purified His-tagged Myo2 CBD from E. coli. Proteins pulled down by
GST (lane 1), GST+GDP (lane 2), GST+GTPgS (lane 3), GST-Sec4-Q79L+GTPgS (lane 4), GST-Sec4-S34N+GDP (lane 5), or GST-Sec4-N133I (lane 6), and 2% of
input His-taggedMyo2 CBD (lane 7) were analyzed by immunoblot with antibody directed against Myo2 CBD or by CBB staining. (C and D) CBB stain of proteins
bound to glutathione beads shows that the levels of GST (negative control) were higher than the levels of GST-Sec4 (test protein).
(E) Sec4 and Myo2 interact in vivo. Myo2-vYFPN and vYFPC-Sec4 coexpressed in myo2D cells interact as indicated by the YFP signal (Ea–Ef). Expression of
Myo2- vYFPN with nontagged Sec4 or vYFPC -Sec4 with nontagged Myo2 showed no fluorescence (Eg–El).
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Myosin V Interacts with the ExocystThe Interaction between Myo2 and Sec4 Is Essential
for Secretory Vesicle Transport
To test whether the lethal point mutation in the center of the Rab-
binding site, myo2-Y1415R, is inviable due to loss of interaction
between Myo2 and Sec4, we expressed Sec4 fused to the
C-terminal end of Myo2-Y1415R (Figure 2A; Figure S2A). Fusion
of the Myo2-Y1415R mutant with Sec4 rescues its lethality
(Figures 2B and 2C). In further support that the interactions
between Myo2 and Ypt31/32 as well as Myo2 and Sec4 are
specific, a fusion of Myo2-Y1415R with the Rab GTPase Ypt11158 Developmental Cell 21, 1156–1170, December 13, 2011 ª2011was generated. Ypt1 is involved in vesicle transport from the
ER to the Golgi and does not bind to Myo2 (Jedd et al., 1997;
Lipatova et al., 2008; Segev et al., 1988). Fusion with Ypt1
does not rescue the lethality of the myo2-Y1415R mutant (Fig-
ure 2B), which indicates that only specific Rab GTPases are
capable of rescuing the lethality. Note that in each experiment,
wild-type Ypt31/32 and Sec4 are present. We also tested and
found that the affinity of Sec4 (GppNHp) for Myo2, KD =
4.6 mM, is modestly greater than the affinity of Ypt32 (GppNHp)
for Myo2, KD = 6.4 mM (Table S1).Elsevier Inc.
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Figure 2. Interaction between Myo2 and Sec4 Is Essential for Yeast Viability
(A) Schematic of Rab GTPase fusions of Myo2. Rab GTPases indicated (B) fused in frame to the C terminus of Myo2. Myo2 motor domain, IQ motifs, coiled-coil
region and CBD, and mutation site of Y1415R (*) are indicated.
(B) Left shows plasmids transformed into a myo2D strain (LWY2947), YCp50 [URA3] MYO2: pRS413 [HIS3] MYO2, pRS413 MYO2-SEC4, pMYO2-YPT32,
pMYO2-YPT1, pmyo2-Y1415R, pmyo2-Y1415R-SEC4, pmyo2-Y1415R-YPT32, or pmyo2-Y1415R-YPT1. Transformed colonieswere restreaked onto SC+5FOA
to counter select against YCp50 [URA3] MYO2 (middle) and on SC-His-Ura to show that the cells received a [HIS3] plasmid (right).
(C)Myo2 fusion proteins expressed at similar levels in SC-His-Uramedium. Cell lysates were analyzed by immunoblot with antibodies directed against Myo2CBD
(top) and Pgk1 (loading control).
(D) Schematic of Sec4 fused at the C terminus of Myo2. Sec4 is geranylgeranylated at two cysteine residues of its C terminus.
(E) Left shows plasmids transformed into amyo2D strain, YCp50 [URA3]MYO2; pRS413 (mock), pMYO2, pmyo2-Y1415R, pMYO2-SEC4, pmyo2-Y1415R-SEC4,
pMYO2 s4-SS, or pmyo2-Y1415R-sec4-SS. Transformed colonies were restreaked onto SC+5FOA (middle) and SC-His-Ura (right).
(F) Myo2 fusion proteins expressed at similar levels in SC-His-Ura medium. Cell lysates of LWY2947 with the indicated plasmid analyzed by immunoblot with
antibodies directed against the Myo2 CBD and Pgk1 (loading control).
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Myosin V Interacts with the ExocystOnly the prenylation competent form of Sec4 rescues
the lethality of myo2-Y1415R mutant (Figures 2D and 2E). The
Sec4-SS mutant, mutated in its predicted prenylation site
(Calero et al., 2003), cannot attach to membranes and does
not suppress the lethality of the myo2-Y1415R mutant (Fig-
ure 2E). Together, these results suggest that the interaction
betweenMyo2 and Sec4 is essential for yeast viability, secretory
vesicle transport, and Myo2 association with secretory vesicles.
All Rab GTPase fusion proteins were expressed at similar levels
(Figures 2C and 2F). In addition, overexpression of Sec4 in the
myo2-Y1415E temperature-sensitive mutant partially rescued
its growth defect (Figure S2B). This finding adds further support
to the hypothesis that themyo2-Y1415E/Rmutants are defective
in binding to Sec4.
Myo2 Interactswith theExocystComplex throughDirect
Interaction with Sec15
The structure of the CBD ofMyo2 is strikingly similar to the struc-
tures of subunits of the exocyst (Dong et al., 2005; Hamburger
et al., 2006; Moore et al., 2007; Munson and Novick, 2006;DevelopmentaPashkova et al., 2006; Sivaram et al., 2006; Wu et al., 2005).
These proteins consist of a-helical bundles. The elongated sides
of the bundles are predicted to form contact sites between the
exocyst subunits (Munson and Novick, 2006). The structural
similarity between these proteins suggested the intriguing possi-
bility that Myo2 may integrate into the exocyst complex. In addi-
tion, one of the exocyst subunits, Sec15, binds directly to Sec4
(Guo et al., 1999). That both Sec15 and Myo2 bind Sec4 poten-
tially places Myo2 near the exocyst.
To test whether the Myo2 CBD interacts with the exocyst, we
performed GST pull-down assays from yeast lysates. Purified
recombinant GST-Myo2 CBD pulled down the entire exocyst
complex (Sec3-vYFP, Sec5-vYFP, Sec6, Sec8-vYFP, Sec10-
vYFP, Sec15, Exo70-vYFP, and Exo84) from solubilized yeast
lysates (Figure 3A). The low levels of Sec3 that are pulled down
by Myo2 are likely due to the degradation of Sec3 (TerBush
et al., 1996), and/or due to the absence of Sec3 on secretory
vesicles (Boyd et al., 2004). Indeed, GST-Sec15 also pulled
down little Sec3 (Figure 3B). Together, these results show that
the Myo2 CBD interacts with the exocyst.l Cell 21, 1156–1170, December 13, 2011 ª2011 Elsevier Inc. 1159
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Figure 3. Myo2 Interacts with the Exocyst through Direct Interaction with Sec15
(A) Myo2 CBD binds the exocyst complex. Purified bacterially expressed GST-Myo2 CBD pulled down Sec3-vYFP, Sec5-vYFP, Sec6, Sec8-vYFP, Sec10-vYFP,
Sec15, Exo70-vYFP, and Exo84 from yeast lysates. Wild-type strains with vYFP-tag fusions integrated at the endogenous locus were utilized.
(B) The amount of Sec3 pulled down with Myo2 was greater than the amount of Sec3 pulled down with Sec15. Pull downs in (A) and (B) were from the same
lysates. Asterisks indicate nonspecific signals.
(C) Sec15 directly binds the Myo2 CBD. Purified GST-Sec15 pulled down bacterially expressed, purified His-tagged Myo2 CBD.
(D) Myo2 CBD directly binds Sec15. Purified GST-Myo2 CBD pulled down bacterially expressed, purified His-tagged Sec15.
(E) GST-Sec10 does not bind to His-Myo2 CBD.
(F) Sec15 and Myo2 interact in vivo. Myo2- vYFPN and Sec15-vYFPC coexpressed in myo2D, sec15D double knock out cells, interact as indicated by the YFP
signal (Fa–Ff). Expression of Myo2-vYFPN with untagged Sec15 or Sec15-vYFPC with untagged Myo2 did not show a YFP signal (Fg–Fl).
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Myosin V Interacts with the ExocystUsing recombinant proteins, we tested whether Myo2 directly
binds to a subunit of the exocyst complex. We tested Sec15
because Sec15 is the most proximal protein in the attachment
of the exocyst to secretory vesicles (Guo et al., 1999). Moreover,
Myo2 (Figure 1) (Santiago-Tirado et al., 2011) and Sec15 (Guo
et al., 1999) each bind Sec4. We observed that recombinant1160 Developmental Cell 21, 1156–1170, December 13, 2011 ª2011GST-Sec15 binds to purified His-tagged Myo2 CBD, and
conversely, recombinant GST-Myo2 CBD also binds to purified
His-tagged Sec15 in vitro (Figures 3C–3E). We also tested
GST-Sec10, which binds to Sec15, and found that GST-Sec10
does not bind Myo2 (Figure 3E). These results indicate that the
CBD of Myo2 directly binds with Sec15. To test whether Myo2Elsevier Inc.
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Myosin V Interacts with the Exocystand Sec15 interact in vivo, we utilized the split GFP system.
Coexpression of Myo2-vYFPN, and Sec15-vYFPC in myo2D,
sec15D double knockout cells displayed a YFP signal in the
bud-tip or mother-bud neck, sites of active polarized growth
(Figure 3F). Note that expression of Myo2-vYFPN and Sec15-
vYFPC rescues the lethality of themyo2D, sec15D doublemutant
(data not shown), which indicates that these fusion proteins are
functional. In addition, as a test of the reliability of the split GFP
assay, we found that bud-tip localized protein Myo4, tagged
with either NYFP or CYFP, gave little to no signal when coex-
pressed with the appropriate fusions of Myo2, Sec15, or Sec4
(Figure S3).
Identification of a Potential Sec15-Binding Site on Myo2
Based on the possibility that the surface area onMyo2 that binds
Sec15 is not identical to the surface that binds Sec4, we
designed a random mutagenesis screen to identify the Sec15-
binding site. The screen is based on the postulate that Myo2
utilizes both Sec4 and Sec15 to attach to secretory vesicles.
Thus, the lethal Sec4-binding site mutant, myo2-Y1415R, might
be suppressed by second site mutations that enhance the ability
of Myo2 to bind to Sec15. We postulated that a subset of the
suppressors may increase Sec15 binding to Myo2 at the bona
fide Sec15-binding region, whereas other suppressors may act
by binding Sec15 through an additional site. Furthermore,
some suppressors might function by enhancing the binding of
Myo2 to another secretory vesicle protein.
To directly test whether the Sec15-binding region could be
narrowed through identification of second site suppressors of
myo2-Y1415R, we performed random PCR mutagenesis of the
coding region of the Myo2-Y1415R CBD, and isolated several
viable Myo2-Y1415R-containing strains and mapped the loca-
tions of the suppressor mutations (Figure S4A). Notably, 18 out
of 23 suppressors mapped to the Myo2 surface, consistent
with the postulate that they function by enhancing the ability of
Myo2 to interact with another protein. We focused on surface
mutations and generated each mutation in the absence of the
Y1415R mutation. None of these mutations on their own ex-
hibited a defect in yeast growth. We then focused on the largest
cluster of suppressors (Figure S4A) and made several point
mutations in residues adjacent to the cluster (Figures S4B
and S4C). In particular, three mutants, R1402E, Q1472E, and
K1473E, exhibited slow growth at all temperatures tested
(Figures 4A–4C). These mutations reveal a patch on the surface
of Myo2 that is distinct from the Rab-binding region (Figure 4A).
Combining the R1402E mutation with either Q1472E or K1473E
resulted in the same growth defect as the R1402E mutation
alone (data not shown).
myo2-R1402E, Q1472E, and K1473E Exhibit Defects
in Secretion
To determine whether thesemyo2 point mutants have secretion
defects, we tested and found that, similar to the myo2-Y1415E
mutant (Lipatova et al., 2008), myo2-R1402E, -Q1472E,
and -K1473E accumulated numerous vesicles as well as other
aberrant membranous structures (Figure 4D). Note that Myo2
has at least five different membranous cargoes. To determine
whether some of the small vesicles observed are indeed
secretory vesicles, we tested for potential defects in the secre-Developmentation of the cell wall modification enzyme endo-b1,3-glucanase
(Bgl2), a commonly studied secretory cargo (Adamo et al.,
1999; Harsay and Bretscher, 1995; He et al., 2007). Invertase
secretion was not assayed because the yeast strains utilized in
our studies lack the SUC2 gene. Consistent with the accumula-
tion of vesicles, all three mutants, as well as myo2-Y1415E,
retained high levels of Bgl2 when compared with the wild-
type control (Figure 4E). These findings indicate that myo2-
R1402E, -Q1472E, and -K1473E are each defective in the
secretory vesicle transport pathway. Note that these mutants
exhibit normal vacuole inheritance (Figure 4F), suggesting that
the overall structure of the CBD is retained.
Myo2-R1402E and -K1473E Show a Defect in Binding
to Sec15
To test whether the mutants were defective in binding to Sec15
in vitro, we chose the two mutations that had the most severe
growth defect, myo2-R1402E and -K1473E, and performed
in vitro binding assays using recombinant proteins. Each mutant
was defective in its interaction with GST-Sec15 (Figure 5A). We
also measured their affinity using SPR, and observed a KD of
0.5 mM for wild-type Myo2 CBD with GST-Sec15 and a KD of
2.5 mM for Myo2-R1402E mutant CBD (Table S1 and Figure S5).
These results suggest that the growth defects of the myo2-
R1402E and -K1473E mutations are due to a defect in binding
to Sec15. We tagged myo2-R1402E, -Q1472E, and -K1473E
with mCherry and found that these mutants localize to sites of
polarized growth, which strongly suggests that themotor activity
is unaffected by these mutations (Figure 5B). Importantly, these
mutants result in a mislocalization of Sec15, which suggests that
Sec15 must bind Myo2 in order to localize to sites of polarized
growth (Figure 5B).
We also tested whether these mutations affect the ability of
Myo2 to interact with Sec4. In a yeast two-hybrid assay, we
found that myo2-R1402E and myo2-K1473E each bind Sec4
(Figure 5C). In in vitro binding experiments, the mutants dis-
played a modest defect in binding Sec4, in contrast with
myo2-Y1415R, which has a major defect in binding Sec4 (Fig-
ure 5D). These finding support the postulate that the slow-
growth phenotype of myo2-R1402E and myo2-K1473E is due
to a defect in binding to Sec15. Together, these studies reveal
an additional surface region on the Myo2 CBD that is required
for yeast growth, and which is distinct from the Rab-binding site.
Identification of a Potential Myo2-Binding Site on Sec15
The interaction between Myo2 and Sec15 may be mediated by
ionic interactions. Note that two of the three Myo2 mutants
(R1402E and K1473E) involve a charge reversal, which suggests
that there are negatively charged amino acids on the surface of
Sec15 that interact directly with Myo2. Although a high-resolu-
tion structure of yeast Sec15 is not available, we used the
high-resolution structure of Drosophila Sec15 (Wu et al., 2005),
and the ESyPred3D program (Lambert et al., 2002), to predict
a structure for yeast Sec15. From an alignment of Sec15 from
four species (human, fly, worm, and yeast), we noted a cluster
of conserved, surface, negatively charged amino acids: D681,
E684, D705 (Figure 6A; Figure S6A). We tested several single-
point mutants: D681K, E684K, and D705K, as well as E687K,
D689K, E694K, D698K, D700K, and D765K. Most mutationsl Cell 21, 1156–1170, December 13, 2011 ª2011 Elsevier Inc. 1161
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Figure 4. Identification of the Potential Sec15-Binding Site on Myo2
(A) Surface representation indicating mutated residues of the Myo2 CBD that show a growth defect (green), Vac17-binding region (blue) (Ishikawa et al., 2003;
Pashkova et al., 2006), and secretory vesicle/Rab GTPase-binding region (red) (Lipatova et al., 2008; Pashkova et al., 2006).
(B) Myo2 mutant proteins expressed at similar levels in SC-His-Ura medium. Cell lysates of LWY2947 with indicated plasmids analyzed by immunoblot with
antibodies directed against Myo2 CBD (top) and Pgk1 (loading control).
(C)myo2-R1402E, -Q1472E, and -K1473Emutants show a growth defect. pRS413MYO2, pmyo2-Y1415E, pmyo2-R1402E, pmyo2-Q1472E, or pmyo2-K1473E
expressed in LWY2947 (myo2D cells). Transformed colonies restreaked onto SC+5FOA to counter select against YCp50 [URA3]MYO2. Colonies from SC+5FOA
were cultured in liquid and serial dilutions spotted on YEPD plates, and incubated at 24C, 30C, or 37C for 2 days.
(D)myo2mutants (Y1415E, R1402E, and K1372E) accumulate small vesicles.myo2mutants and corresponding wild-type cells grown to early log phase in YEPD
at 24C. Cells were prepared for electron microscopy, and ultrathin sections were stained. Scale bars, 0.5 mm.
(E) Bgl2 secretion is blocked in the myo2 mutants. Accumulation of Bgl2 measured by western blot using a-Bgl2 antibody (top). Bgl2 intensity normalized to
an internal loading control (ADH; bottom). Units of intensity between wild-type andmutants were significant; p < 0.05 (Student’s t test). Error bars indicate ±SEM;
n = 5. Strains grown at 24C.
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Figure 5. Myo2-R1402E and -K1473E Show a Defect in Binding to Sec15
(A) myo2-R1402E and -K1473E mutants are defective in binding Sec15 in vitro. Bacterially expressed, purified His-tagged Myo2-R1402E and -K1473E CBDs
have a defect in binding to purified GST-Sec15.
(B) Sec15 is mislocalized in myo2 mutants, myo2-R1402E, -Q1472E, and -K1473E. Coexpression of vYFP-Sec15 and mCherry-Myo2 (wild-type, R1402E,
Q1472E, or K1473E) in myo2D, sec15D double knock out cells (LWY10970).
(C) Themyo2-R1402E, -Q1472E, and -K1473Emutants do not block the ability of Myo2 to bind to Sec4. Yeast two-hybrid test of theMyo2 CBD or mutated Myo2
CBDs, fused with the Gal4 DNA-binding domain (BD) and tested for interaction with Sec4 or Vac17 fused with the Gal4 activation domain (AD).
(D) In in vitro binding experiments, the Myo2 mutants, R1402E and K1473E, displayed a modest defect in binding Sec4-GTPgS, in contrast with Myo2-Y1415R,
which has a major defect in binding Sec4. Purified GST-Sec4 pulled down purified His-tagged Myo2-CBD from E. coli. Proteins pulled down by GST (lanes 1–4),
GST-Sec4 (lanes 5–9), and input His-tagged Myo2-CBDs (lanes 10–13) were analyzed by immunoblot with antibody directed against Hisx6 or by Ponceau S
staining.
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Myosin V Interacts with the Exocystdid not alter the in vivo function of Sec15. However, the sec15-
D705K single mutant and sec15-D681K/E684K double mutant
were lethal (Figure 6B). Note that the vYFP-tagged Sec15mutant
proteins were expressed at similar levels (Figure 6C). Also, the
sec15 mutants with or without the vYFP tag are lethal (data not
shown). Importantly, the lethal mutants, Sec15-D681K/E684K
and -D705K, are mislocalized (Figure 6D). This result parallels
the finding that Sec15 is mislocalized in myo2 mutants that(F) myo2-R1402E, -Q1472E, and -K1473E mutants suppress the vacuole inherita
mutant (LWY5516). Quantitative analysis of vacuole inheritance. Vacuole inheritan
bars, normal vacuole inheritance; black bars, bud without detectable FM4-64; gra
calculated from at least three experiments. Over 170 cells counted.
Developmentahave a defect in binding to Sec15 (Figure 5B). Together, these
findings strongly suggest that contact between Myo2 and
Sec15 is important for Sec15 localization and yeast viability.
Note that the two lethal Sec15 mutants are able to assemble
into the exocyst complex. We performed immunoprecipitation
experiments using Sec15-TAP, wild-type, D681K/E684K, or
D705K expressed in a strain containing SEC10-vYFP. These
studies showed that wild-type Sec15-TAP as well as mutantnce defect in myo2-2 cells. Indicated plasmids were expressed in the myo2-2
cewas assessed as the percent cells with an inherited vacuole in the bud.White
y bars, weaker FM4-64 signal in the bud than in the mother cell. Error bars, SD
l Cell 21, 1156–1170, December 13, 2011 ª2011 Elsevier Inc. 1163
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Figure 6. Identification of the Myo2-Binding Region on Sec15
(A) Model for the structure of yeast Sec15, indicating negatively charged residues (cyan) and conserved negatively charged residues (blue).
(B) Left shows plasmids transformed into a sec15D strain: pRS415 (mock), pSEC15, pvYFP-SEC15, pvYFP-sec15-D681K/E684K, pvYFP-sec15-D700K, pvYFP-
sec15-D705K. Transformed colonies restreaked on SC+5FOA (middle) and SC-Leu-Ura (right).
(C) Sec15 protein expressed at similar levels in SC-Leu-Ura medium. Cell lysates of LWY10491 with indicated plasmids were analyzed by immunoblot with
antibodies directed against Sec15, GFP, and Pgk1 (loading control).
(D) Lethal Sec15 mutants, D681K/E684K and D705K, are mislocalized. Wild-type yeast (LWY7235) containing the indicated plasmids was visualized by fluo-
rescence microscopy.
(E) The Sec15-D705K mutant shows a defect in binding Myo2 in vitro. Bacterially expressed, purified GST-Sec15(577-910)-D705K has a defect in binding
purified His-tagged Myo2 CBD, but not purified His-tagged Sec4-Q79L.
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Myosin V Interacts with the ExocystSec15-TAP, D681K/E684K, or D705K pulled down the exocyst
subunits tested, Sec10-vYFP, Sec6, and Exo84 (Figure S6B).
To test whether these Sec15 mutants are defective in binding
to Myo2, we performed GST pull-down experiments using puri-
fied proteins from E. coli. Notably, the Sec15-D705Kmutant was
defective in binding to Myo2, but not in binding to Sec4 (Fig-
ure 6E). To further test the ability of the Sec15 mutants to bind
toMyo2, we performed split-GFP experiments usingMyo2 fused
with vYFPN and tested for interaction with the Sec15 mutants
fused with vYFPC. We found that Sec15-D681K/E684K and
-D705K are defective in binding to Myo2 in vivo (Figure S6C).
Note that these proteins were expressed at levels similar to
wild-type Sec15-vYFPC.
If the interaction between Myo2 and Sec15 is mediated in part
by ionic interactions, then charge reversal of one or two amino
acids on the surface of Sec15 might potentially suppress the
growth defect of myo2-R1402E, -Q1472E, or -K1473E. To test
this hypothesis, we analyzed each of the Sec15 mutants gener-
ated above and found that the sec15-D700Kmutant significantly
suppressed the growth defect of the myo2-R1402E, -Q1472E,
or -K1473Emutants (Figure 6F). That a charge reversal of a single
residue on Sec15 compensates each of three mutations caused
by introduction of a negatively charged surface residue onMyo2,
provides very strong support for the hypothesis that Myo2 and
Sec15 interact with each other directly in vivo, and that this
interaction is critical for normal yeast growth. Moreover, these
results strongly suggest that Myo2 and Sec15 bind in part
through ionic interactions, and that amino acids, R1402,
Q1472, and K1473 on Myo2, and D681, E684, D700, and D705
on Sec15 are involved in this interaction. Note that we did
not pursue approaches to test whether the charge-reversal
mutation, Sec15-D700K, rescues the binding defect of Myo2-
R1402E and -K1473E to Sec15 in vitro because recombinant
Sec15-D700K protein is not sufficiently soluble.Mammalian Myosin Va Interacts with the Exocyst
Complex
Most surface residues on Myo2 that bind Sec15 are conserved
from yeast to mammals (Figure S7A). Moreover, most of the pre-
dicted surface residues on Sec15 critical for Myo2 interaction
with Sec15 are conserved (Figure 6; Figure S6). These observa-
tions strongly suggest that the interaction betweenmyosin V and
the exocyst is conserved. To test whether mouse myosin Va
interacts with the mouse exocyst, we performed GST pull-
down assays from detergent-solubilized lysates prepared from
cultured mouse NIH 3T-3 cells. Recombinant GST-myosin Va
GTD pulled down the mammalian exocyst, as measured by the
presence of the two exocyst subunits tested: Sec6 and Sec8
(Figure 7A). We also tested and found that recombinant GST-
rSec15 binds to purified His-tagged myosin Va GTD in vitro (Fig-
ure 7B). These results indicate that myosin Va directly binds with
Sec15 through its GTD, and strongly predict that the interaction(F) The sec15-D700K mutant suppresses the growth defect of the myo2 mutant
double KO strain: pRS413 MYO2 plus pRS415 SEC15, pmyo2-R1402E plus p
pmyo2-Q1472E plus psec15-D700K, pmyo2-K1473E plus pSEC15, or pmyo2-K1
select against YCp50 [URA3] SEC15/MYO2. Colonies from SC+5FOA were cultur
30C, or 37C for 4 days.
Developmentabetweenmyosin V and the exocyst complex is conserved, and is
critical for vesicle transport in mammals.
DISCUSSION
A striking prediction of these studies is that the myosin V motor,
Myo2, is present at each step of secretory vesicle transport
(Figure 8). We previously reported that Myo2 binds directly to
Ypt31/32 (Rab11 homologs), the Rab GTPase pair required for
secretory vesicle formation. Here we show that Myo2 binds
directly to Sec4 (Rab8/10 homolog), the Rab GTPase required
for secretory vesicle fusion with the plasma membrane (this
study) (Santiago-Tirado et al., 2011). We also show that Myo2
binds directly to Sec15, a subunit of the exocyst-tethering
complex. Together, the observations that Myo2 contacts
Ypt31/32, Sec4, and the exocyst strongly suggest that Myo2 is
present prior to the completion of vesicle formation and remains
attached during the final steps of vesicle fusion.
Based on previous studies that order the activities of Ypt31/
32, Sec4, and the exocyst, we propose a model for how Myo2
is integrated into each step of the secretory vesicle pathway.
During production of secretory vesicles via Ypt31/32, Myo2 is
recruited to vesicles through interaction of its CBD with the
Rab GTPases Ypt31/32. The fact that the GTP-bound rather
thanGDP-bound Ypt31/32 interact with theMyo2CBD (Lipatova
et al., 2008) provides strong support for the hypothesis that
Myo2 is present before post-Golgi vesicles are fully formed.
The CBD of Myo2 also binds the Rab GTPase Sec4. That
Ypt31/32 and Sec4 bind the same region of Myo2 (this study),
and that SEC4 functions downstream of YPT31/32 (Ortiz et al.,
2002), suggests that Myo2 may interact first with Ypt31/32 and
then with Sec4. We postulate that Ypt32 and Sec4 bind the
Myo2 CBD at distinct times in the life of post-Golgi vesicles.
Myo2 also binds to Sec15 and interacts indirectly with the rest
of the exocyst. The attachment of Myo2 to Sec15 may occur
simultaneously with Myo2 interaction with Sec4 or may be a
separate step.
Myo2 Directly Contacts Additional Proteins Related
to Secretory Vesicle Fusion
TheMyo2 CBD (residues 1131–1574) binds Ypt31/32, Sec4, and
Sec15. Notably, other regions of Myo2 also interact with addi-
tional proteins required for fusion of secretory vesicles with the
plasma membrane. The neck region of Myo2 (871–1204 aa)
associates with the small GTPase Rho3 whose effector is the
exocyst subunit Exo70 (Robinson et al., 1999). An overlapping
region of Myo2 (782–990 aa) interacts with Sro7 (Gangar et al.,
2005; Rossi and Brennwald, 2011), a conserved Lgl family
member, which interacts with Sec4 and the t-SNARE, Sec9
(Grosshans et al., 2006; Lehman et al., 1999), and is required
for fusion of secretory vesicles with the plasma membrane.
Indeed, a recent study suggests that Myo2 negatively regulatess, R1402E, Q1472E, or K1473E. Plasmids transformed into a myo2D, sec15D
SEC15, pmyo2-R1402E plus psec15-D700K, pmyo2-Q1472E plus pSEC15,
473E plus psec15-D700K. Transformants restreaked on SC+5FOA to counter
ed in liquid and serial dilutions spotted on YEPD plates, and incubated at 24C,
l Cell 21, 1156–1170, December 13, 2011 ª2011 Elsevier Inc. 1165
A B Figure 7. Mammalian Myosin Va Interacts with the
Exocyst Complex
(A) Purified GST-mouse myosin Va GTD pulled down each
exocyst subunit tested, Sec6 and Sec8, from solubilized
S100 lysates from NIH 3T3 cells. Proteins pulled down by
GST (lane 1) or GST-mMyosin Va GTD (lane 2), and input
S100 (lane 3) analyzed by immunoblot with antibodies
directed against Sec6, Sec8, or by CBB stain.
(B) mMyosin Va GTD directly binds to rat Sec15 in vitro.
Purified GST-rSec15 pulled down purified His-tagged
mMyosin Va GTD from E. coli. Proteins pulled down by
GST (lane 1), GST-rSec15 (lane 2 and 3), and input His-
tagged mMyosin Va GTD (lane 4) analyzed by immunoblot
with antibody directed against Hisx6 or by CBB stain.
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Myosin V Interacts with the Exocystthe late fusion pathway via its interaction with Sro7 (Gangar et al.,
2005; Rossi and Brennwald, 2011), which in turn binds with
Exo84 (Zhang et al., 2005). That Myo2 interacts with so many
proteins related to late steps in vesicle fusion provides further
support to the postulate that Myo2 remains attached to vesicles
until very late in the fusion pathway. We propose that these
proteins anchor Myo2 to secretory vesicles during vesicle trans-
port. Moreover, Myo2 may function as a scaffold that organizes
membrane tethering and/or fusion.
Rab GTPase and Exocyst-Binding Sites on Myosin V
Are Conserved
We speculate that the Rab cascade in vesicle movement, as well
as a role for myosin V in this cascade, is partially conserved. The
degree of sequence similarity between yeastMyo2 andmamma-
lian myosin Va, Vb, and Vc enabled us to predict a three-dimen-
sional model for CBD of these three mammalian myosin V
motors. Alignment of the CBDs of mammalian myosin Va, Vb,
and Vc with yeast Myo2 reveals that there is conservation of
the predicted surface residues that bind to Ypt31/32 and Sec4
(Figure S7) (Lipatova et al., 2008), as well as the two predicted
surface residues that contact Sec15. Similarly, the predicted
Myo2-binding site on Sec15 is conserved (Figure S6A). Indeed,
we tested and found that mammalian myosin Va pulls down
the mammalian exocyst from cell lysates, and interacts with
recombinant mammalian Sec15 (Figure 7).
Our findings fit with several studies on metazoan myosin V
motors. Mammalian myosin Va, Vb, and Vc have been shown
to interact with multiple Rab GTPases, including Rab8, Rab10,
Rab11, and Rab27 (Fukuda et al., 2002; Hume et al., 2002;1166 Developmental Cell 21, 1156–1170, December 13, 2011 ª2011 Elsevier Inc.Ishikura and Klip, 2008; Nagashima et al.,
2002; Rodriguez and Cheney, 2002; Roland
et al., 2009; Strom et al., 2002; Wu et al.,
2002). Importantly, myosin Vb associates with
Rab11 (Ypt31/32-like) and also Rab8 (Sec4-
like) (Roland et al., 2007, 2011). Moreover,
Rab11 binds the region of myosin Vb that corre-
sponds precisely with the region on Myo2 that
binds to Ypt31/32, whereas Rab8 binds to
a region upstream of the GTD (Roland et al.,
2011). Thus, Rab11-related and Rab8-related
GTPases may interact sequentially with myosin
V motors in several membrane transport path-
ways in ways that are similar to Rab GTPaseinteractions with yeast Myo2. In addition, Rab11 also associates
with the exocyst both in mammals (Fielding et al., 2005; Zhang
et al., 2004) and in Drosophila (Beronja et al., 2005; Jafar-Nejad
et al., 2005; Langevin et al., 2005; Wu et al., 2005).
Residues in the Sec15-binding site on mouse myosin Va have
also been predicted to function in another capacity. In vitro,
mammalian myosin V motors are autoinhibited by the GTD in
the absence of cargo binding. This head-tail interaction inhibits
the ATPase cycle of the myosin Va motor (Li et al., 2008; Liu
et al., 2006; Olivares et al., 2006; Thirumurugan et al., 2006)
Importantly, mutation of the two residues on myosin Va, K1706
and K1779, that correspond with R1402 and K1473 on Myo2,
blocks the in vitro interaction of the myosin Va motor and CBD
(Li et al., 2008). Note that it is not yet known whether the motor
andCBDs ofmyosin Va interact in vivo.Moreover, the physiolog-
ical significance of this interaction has not been determined.
Importantly, it is not known whether this type of interaction
occurs in Myo2. However, collectively, these findings raise the
possibility that Sec15 and the exocyst compete with the myosin
Va motor for access to the myosin Va GTD.
It is not clear whether binding to RabGTPases and the exocyst
is conserved among all myosin V motors. The structure of the
CBD of Myo4 is similar to Myo2 (Heuck et al., 2010) (Figure S7E).
However, in preliminary studies, Myo4 did not bind to the
exocyst (Heuck et al., 2010). Indeed, analysis of the structure
of Myo4 does not provide a clear prediction of whether Myo4
binds to either a Rab GTPase or to the exocyst. Two of the five
Rab GTPase-binding residues are conserved, whereas only
one of the three Sec15-binding residues is conserved in Myo4
(Figures S7A and S7E).
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Figure 8. Model of the Direct Association of Myo2 with Each Step in
the Life of a Secretory Vesicle
Myosin V is present at each of the exocytic vesicle transport steps.
For simplicity, only those vesicle-related molecules that have been demon-
strated to interact with the CBD of Myo2 are shown. Ypt31/32 are required
for production of secretory vesicles from the trans-Golgi (Jedd et al., 1997).
GTP-bound Ypt31/32 also bind directly to Myo2 (Lipatova et al., 2008). GTP-
bound Sec4 binds Myo2 (this study; Santiago-Tirado et al., 2011). Sec15
binds both Myo2 and GTP-bound Sec4 (this study). Other exocyst sub-
units are recruited to the vesicles. Secretory vesicles fuse with the plasma
membrane. The precise order of each of these events is not yet established.
In this model Myo2 binds to vesicles before they are released from a post-
Golgi compartment, and remains attached until very late in the fusion
pathway.
Developmental Cell
Myosin V Interacts with the ExocystThe Structure of the Myo2 CBD Is Conserved with Other
Tethering Complexes
Because there is no sequence similarity, it was initially surprising
to discover that the Myo2 CBD shares a similar fold with the
exocyst subunits. Furthermore, there is very little sequence
conservation between the exocyst subunits. Thus, it is currently
not possible to predict how many more examples exist of
proteins with this same fold. However, judging from recent
studies, this fold may be widely shared among diverse tethering
factors.
High-resolution structures of subunits of the conserved oligo-
meric Golgi (COG) complex, a vesicle-tethering complex for
retrograde traffic in the Golgi, have a similar structure with the
known exocyst subunits and with Myo2 (Cavanaugh et al.,
2007; Richardson et al., 2009). Moreover, the Dsl1-tethering
complex, which functions in retrograde traffic from the Golgi to
the ER, and Vps53, amember of theGolgi-associated retrograde
protein (GARP)-tethering complex that functions in retrograde
traffic from endosomes to the trans-Golgi, also have a similar
structure with exocyst subunits and Myo2 (Pe´rez-Victoria
et al., 2010; Ren et al., 2009; Tripathi et al., 2009; Vasan et al.,
2010). Thus, integration of the myosin V GTD into vesicle-teth-
ering complexes may be a common mechanism that couples
diverse membrane cargoes to myosin V, and further ensures
that the motor remains attached until late in the fusion pathway.
Furthermore, other motors may contain CBDs with similar struc-
tures that join with tethering factors to couple vesicle formation,
movement, tethering, and fusion.DevelopmentaEXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for further details.
Yeast Strain and Media
Yeast strains used are in Table S2. Yeast cultures were grown at 24C unless
stated otherwise. Yeast extract-peptone-dextrose (1% yeast extract, 2%
peptone, 2% dextrose; YEPD), synthetic complete (SC) lacking the appro-
priate supplement(s), and 5-FOA media were made as described (Kaiser
et al., 1994). Unless stated otherwise, SC medium contained 2% dextrose.
Fibroblast Cell Culture
NIH 3T-3 mouse embryonic fibroblast cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal bovine serum.
Plasmids
Plasmids used are in Table S3.
GST Pull-Down Assay
GST and all GST fusion proteins were expressed in E. coli BL21 DE3 star.
Recombinant proteins were purified with glutathione Sepharose beads (GE
Healthcare).
Random Mutagenesis of MYO2
To obtain a second site mutation that suppressed the lethality of myo2-
Y1415R, the myo2-Y1415R tail region from pRS426 myo2-Y1415R was PCR
amplified with Taq polymerase.
Western Blot Analysis
SDS-PAGE and western blot analysis were performed using standard
procedures.
SPR
Purified GST-Sec15 and Myo2 (CBD) were coupled to a CM5 chip and are
referred to as ‘‘ligands.’’ SPR experiments were performed at 20C on a
Biacore X100 system (GE Healthcare) using a common running buffer, except
that Ypt32 and Sec4 buffers were supplemented with 5 mM MgCl2.
Bgl2 Assay
Bgl2 assays were performed as described (Adamo et al., 1999).
Electron Microscopy
Cells were grown in rich medium to early log phase: 24C, fixed, and prepared
as described (Wuestehube et al., 1996). Thin sections were examined under
a CM10 electron microscope (Philips Electron Instruments, Eindhoven, The
Netherlands).
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.devcel.2011.10.009.
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